Related Experiment Videos
The micronucleus assay as a test for the detection of aneugenic activity
P Vanparys1, F Vermeiren, M Sysmans
1Department of Toxicology, Janssen Pharmaceutica, Beerse, Belgium.
Abstract:
The aim of this work was to determine the usefulness of the micronucleus assay for the detection of aneugenic potential. Chemicals affecting microtubule assembly, i.e., colchicine, vinblastine sulfate and tubulazole, and chemicals affecting targets other than microtubuli, i.e., mitomycin C, cyclophosphamide and miconazole, and the clastogens azathioprine and procarbazine were administered once orally or intraperitoneally to male and female mice. Bone marrow preparations were made at 24, 48 and 72 h after dosing. All the clastogens and aneugens, except miconazole, yielded positive results in the micronucleus test. Measurements of the area of the micronuclei and their distribution clearly showed that the chemicals affecting microtubule assembly produced larger micronuclei than did the clastogens. The pattern of area distribution of the micronuclei found with cyclophosphamide and mitomycin C was between those found for the tubulin inhibitors and the clastogens. These findings indicate that the micronucleus test not only detects chemicals affecting microtubule assembly, but also can discriminate them from clastogens by measurements of the area of the micronuclei.
Insights
The micronucleus assay effectively detects aneugenic chemicals. Measuring micronuclei size helps distinguish between microtubule inhibitors and clastogens, improving genotoxicity testing.
Area of Science:
- Toxicology
- Genetics
- Cell Biology
Background:
- The micronucleus assay is a standard method for detecting genotoxicity.
- Distinguishing between aneugens (affecting microtubules) and clastogens (causing DNA breaks) is crucial for risk assessment.
Purpose of the Study:
- To evaluate the micronucleus assay's utility in detecting aneugenic potential.
- To determine if micronuclei size can differentiate between aneugens and clastogens.
Main Methods:
- Mice were administered various aneugens (colchicine, vinblastine sulfate, tubulazole) and clastogens (mitomycin C, cyclophosphamide, azathioprine, procarbazine) orally or intraperitoneally.
- Bone marrow was collected at 24, 48, and 72 hours post-administration.
- Micronuclei were analyzed for size and distribution.
Main Results:
- The micronucleus test identified most clastogens and aneugens, except miconazole.
- Chemicals affecting microtubule assembly produced significantly larger micronuclei compared to clastogens.
- Cyclophosphamide and mitomycin C showed intermediate micronuclei size patterns.
Conclusions:
- The micronucleus assay is valuable for detecting aneugenic potential.
- Micronuclei size measurement enhances the assay's ability to discriminate between microtubule inhibitors and clastogens.
- This discrimination capability improves the accuracy of genotoxicity assessment.